Lipidomics reveals phosphatidylserine (20:4/20:4) as a novel biomarker for delayed neurocognitive recovery in clinical and animal aging models.
Lipids in health and disease · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
AnimalsBiomarkersHumansPhosphatidylserinesFemaleAgedMaleLipidomicsAgingMiceROC CurveCognitive DysfunctionAged, 80 and overDisease Models, AnimalLipid Metabolism
Come citare questo studio
Dayu Liu, Yunruoxue Lu, Weilei Zheng, Lei Zhang, Shoushi Wang. (2026). Lipidomics reveals phosphatidylserine (20:4/20:4) as a novel biomarker for delayed neurocognitive recovery in clinical and animal aging models.. Lipids in health and disease. DOI: 10.1186/s12944-026-02978-3
Consulta la pubblicazione originale ↗